BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33290947)

  • 21. Bioengineered Microtissue Models of the Human Bone Metastatic Microenvironment: A Novel In Vitro Theranostics Platform for Cancer Research.
    Bock N
    Methods Mol Biol; 2019; 2054():23-57. PubMed ID: 31482446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MTA1 drives malignant progression and bone metastasis in prostate cancer.
    Kumar A; Dhar S; Campanelli G; Butt NA; Schallheim JM; Gomez CR; Levenson AS
    Mol Oncol; 2018 Sep; 12(9):1596-1607. PubMed ID: 30027683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction.
    Yuen HF; Kwok WK; Chan KK; Chua CW; Chan YP; Chu YY; Wong YC; Wang X; Chan KW
    Carcinogenesis; 2008 Aug; 29(8):1509-18. PubMed ID: 18453541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of S100A4 for bone metastasis in prostate cancer cells.
    Kim B; Jung S; Kim H; Kwon JO; Song MK; Kim MK; Kim HJ; Kim HH
    BMC Cancer; 2021 Feb; 21(1):137. PubMed ID: 33549040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway.
    Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Das SK; Sarkar D; Fisher PB
    Mol Cancer Ther; 2018 Sep; 17(9):1951-1960. PubMed ID: 29934341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.
    Chu GC; Zhau HE; Wang R; Rogatko A; Feng X; Zayzafoon M; Liu Y; Farach-Carson MC; You S; Kim J; Freeman MR; Chung LW
    Endocr Relat Cancer; 2014 Apr; 21(2):311-26. PubMed ID: 24478054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells.
    McGovern JA; Bock N; Shafiee A; Martine LC; Wagner F; Baldwin JG; Landgraf M; Lahr CA; Meinert C; Williams ED; Pollock PM; Denham J; Russell PJ; Risbridger GP; Clements JA; Loessner D; Holzapfel BM; Hutmacher DW
    Commun Biol; 2021 Aug; 4(1):1014. PubMed ID: 34462519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt/β-Catenin Signaling Pathway Regulates Osteogenesis for Breast Cancer Bone Metastasis: Experiments in an
    Kar S; Jasuja H; Katti DR; Katti KS
    ACS Biomater Sci Eng; 2020 May; 6(5):2600-2611. PubMed ID: 33463270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate Cancer Phenotype Influences Bone Mineralization at Metastasis: A Study Using an In Vitro Prostate Cancer Metastasis Testbed.
    Molla MS; Katti DR; Iswara J; Venkatesan R; Paulmurugan R; Katti KS
    JBMR Plus; 2020 Feb; 4(2):e10256. PubMed ID: 32083238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis.
    Sieh S; Taubenberger AV; Lehman ML; Clements JA; Nelson CC; Hutmacher DW
    Bone; 2014 Jun; 63():121-31. PubMed ID: 24530694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium phosphate scaffolds with defined interconnecting channel structure provide a mimetic 3D niche for bone marrow metastasized tumor cell growth.
    Aveic S; Davtalab R; Vogt M; Weber M; Buttler P; Tonini GP; Fischer H
    Acta Biomater; 2019 Apr; 88():527-539. PubMed ID: 30797105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors.
    Lescarbeau RM; Seib FP; Prewitz M; Werner C; Kaplan DL
    PLoS One; 2012; 7(8):e40372. PubMed ID: 22870197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The twist box domain is required for Twist1-induced prostate cancer metastasis.
    Gajula RP; Chettiar ST; Williams RD; Thiyagarajan S; Kato Y; Aziz K; Wang R; Gandhi N; Wild AT; Vesuna F; Ma J; Salih T; Cades J; Fertig E; Biswal S; Burns TF; Chung CH; Rudin CM; Herman JM; Hales RK; Raman V; An SS; Tran PT
    Mol Cancer Res; 2013 Nov; 11(11):1387-400. PubMed ID: 23982216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue engineering a surrogate niche for metastatic cancer cells.
    Seib FP; Berry JE; Shiozawa Y; Taichman RS; Kaplan DL
    Biomaterials; 2015 May; 51():313-319. PubMed ID: 25771021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts.
    Shokoohmand A; Ren J; Baldwin J; Atack A; Shafiee A; Theodoropoulos C; Wille ML; Tran PA; Bray LJ; Smith D; Chetty N; Pollock PM; Hutmacher DW; Clements JA; Williams ED; Bock N
    Biomaterials; 2019 Nov; 220():119402. PubMed ID: 31400612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
    Thalmann GN; Sikes RA; Wu TT; Degeorges A; Chang SM; Ozen M; Pathak S; Chung LW
    Prostate; 2000 Jul; 44(2):91-103 Jul 1;44(2). PubMed ID: 10881018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.